{"entity":{"type":"insider","cik":"0001383242","url":"/insider/0001383242","json_url":"/insider/0001383242.json","name":"Scibetta James S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":17,"first":"2011-02-16","last":"2019-08-22","span_basis":"filed_date"},"name_variants":[{"name":"Scibetta James S","source":"filing","n_filings":17,"first_seen":"2011-02-16","last_seen":"2019-08-22"}],"transactions":[{"id":8214500,"accession":"0001214659-19-005414","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-19-005414","line_url":"/filing/0001214659-19-005414#line-3","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":3429.0,"total_display":"3,429.00","total_whole":"3,429","shares_owned_after":31635.0,"shares_owned_after_display":"31,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-22","scope":"insider"},{"id":8214497,"accession":"0001214659-19-005414","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-19-005414","line_url":"/filing/0001214659-19-005414#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11310.0,"shares_display":"11,310","price_per_share":3.802,"price_display":"3.80","price_state":"stated","total_value":43000.62,"total_display":"43,000.62","total_whole":"43,001","shares_owned_after":30735.0,"shares_owned_after_display":"30,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-22","scope":"insider"},{"id":8214491,"accession":"0001214659-19-005414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-005414","line_url":"/filing/0001214659-19-005414#line-1","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10761.0,"shares_display":"10,761","price_per_share":3.768,"price_display":"3.77","price_state":"stated","total_value":40547.448,"total_display":"40,547.45","total_whole":"40,547","shares_owned_after":19425.0,"shares_owned_after_display":"19,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-22","scope":"insider"},{"id":4734638,"accession":"0000905718-17-000823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000823","line_url":"/filing/0000905718-17-000823#line-1","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Matinas BioPharma Holdings, Inc.","issuer_ticker":"MTNB","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":418309.0,"shares_owned_after_display":"418,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-07","scope":"insider"},{"id":4266819,"accession":"0001209191-17-038420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-038420","line_url":"/filing/0001209191-17-038420#line-1","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1966.0,"shares_display":"1,966","price_per_share":43.321,"price_display":"43.32","price_state":"stated","total_value":85169.086,"total_display":"85,169.09","total_whole":"85,169","shares_owned_after":25118.0,"shares_owned_after_display":"25,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-07","scope":"insider"},{"id":4357883,"accession":"0001209191-17-033404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033404","line_url":"/filing/0001209191-17-033404#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.2,"price_display":"51.20","price_state":"stated","total_value":1024000.0,"total_display":"1,024,000.00","total_whole":"1,024,000","shares_owned_after":27084.0,"shares_owned_after_display":"27,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"},{"id":5059511,"accession":"0001209191-17-004637","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-004637","line_url":"/filing/0001209191-17-004637","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":38.534913,"price_display":"38.53","price_state":"stated","total_value":770698.26,"total_display":"770,698.26","total_whole":"770,698","shares_owned_after":32081.0,"shares_owned_after_display":"32,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider","n_lines":2},{"id":3046290,"accession":"0001209191-16-150960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-150960","line_url":"/filing/0001209191-16-150960#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":36.5,"price_display":"36.50","price_state":"stated","total_value":730000.0,"total_display":"730,000.00","total_whole":"730,000","shares_owned_after":27084.0,"shares_owned_after_display":"27,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-17","scope":"insider"},{"id":3129008,"accession":"0001209191-16-137674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-137674","line_url":"/filing/0001209191-16-137674#line-3","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":45.21,"price_display":"45.21","price_state":"stated","total_value":1130250.0,"total_display":"1,130,250.00","total_whole":"1,130,250","shares_owned_after":27084.0,"shares_owned_after_display":"27,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":8727249,"accession":"0001209191-15-070574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-070574","line_url":"/filing/0001209191-15-070574#line-1","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":61.37,"price_display":"61.37","price_state":"stated","total_value":306850.0,"total_display":"306,850.00","total_whole":"306,850","shares_owned_after":10504.0,"shares_owned_after_display":"10,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-14","scope":"insider"},{"id":8367548,"accession":"0001181431-15-002198","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-15-002198","line_url":"/filing/0001181431-15-002198","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":111.224946,"price_display":"111.22","price_state":"stated","total_value":1668374.19,"total_display":"1,668,374.19","total_whole":"1,668,374","shares_owned_after":10033.0,"shares_owned_after_display":"10,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-09","scope":"insider","n_lines":4},{"id":6834821,"accession":"0001181431-14-036262","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-036262","line_url":"/filing/0001181431-14-036262","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":87.17613333333334,"price_display":"87.18","price_state":"stated","total_value":1307642.0,"total_display":"1,307,642.00","total_whole":"1,307,642","shares_owned_after":9100.0,"shares_owned_after_display":"9,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2014-11-12","scope":"insider","n_lines":5},{"id":6723315,"accession":"0001181431-14-028871","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-028871","line_url":"/filing/0001181431-14-028871","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":99.62666666666667,"price_display":"99.63","price_state":"stated","total_value":1494400.0,"total_display":"1,494,400.00","total_whole":"1,494,400","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-08","filed_date":"2014-08-11","scope":"insider","n_lines":2},{"id":6308261,"accession":"0001181431-14-018952","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-018952","line_url":"/filing/0001181431-14-018952","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":75.0454,"price_display":"75.05","price_state":"stated","total_value":1125681.0,"total_display":"1,125,681.00","total_whole":"1,125,681","shares_owned_after":5300.0,"shares_owned_after_display":"5,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-08","filed_date":"2014-05-09","scope":"insider","n_lines":3},{"id":6334847,"accession":"0001181431-14-000239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-000239","line_url":"/filing/0001181431-14-000239#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.55,"price_display":"55.55","price_state":"stated","total_value":555500.0,"total_display":"555,500.00","total_whole":"555,500","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-30","filed_date":"2014-01-02","scope":"insider"},{"id":5554665,"accession":"0001181431-13-052149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-052149","line_url":"/filing/0001181431-13-052149#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.74,"price_display":"46.74","price_state":"stated","total_value":467400.0,"total_display":"467,400.00","total_whole":"467,400","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-30","filed_date":"2013-10-02","scope":"insider"},{"id":4284874,"accession":"0001181431-13-038199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-038199","line_url":"/filing/0001181431-13-038199#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.046,"price_display":"28.05","price_state":"stated","total_value":280460.0,"total_display":"280,460.00","total_whole":"280,460","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-02","scope":"insider"},{"id":5526741,"accession":"0001104659-13-026248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-13-026248","line_url":"/filing/0001104659-13-026248#line-2","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.49,"price_display":"28.49","price_state":"stated","total_value":284900.0,"total_display":"284,900.00","total_whole":"284,900","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-28","filed_date":"2013-04-01","scope":"insider"},{"id":9160376,"accession":"0001181431-11-010930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-010930","line_url":"/filing/0001181431-11-010930#line-1","is_derivative":false,"issuer_cik":"0001383242","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001383242","owner_cik":"0001383242","owner_name":"Scibetta James S","owner_display_name":"Scibetta James S","owner_url":"/insider/0001383242","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.04,"price_display":"7.04","price_state":"stated","total_value":35200.0,"total_display":"35,200.00","total_whole":"35,200","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-15","filed_date":"2011-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Director","n_filings":1,"first_seen":"2019-08-22","last_seen":"2019-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001582554","name":"Matinas BioPharma Holdings, Inc.","url":"/issuer/0001582554","role":"Director","n_filings":1,"first_seen":"2017-09-07","last_seen":"2017-09-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira Pharmaceuticals, Inc.","url":"/issuer/0001396814","role":"Officer (President)","n_filings":15,"first_seen":"2011-02-16","last_seen":"2017-06-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001383242","retrieved_at":"2026-08-25T11:12:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}